Dr. Coffey is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
223 N Van Dien Ave
Ridgewood, NJ 07450Phone+1 201-447-8512
Summary
- Dr. Dennis Coffey is a pediatrician in Ridgewood, NJ and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and Valley Hospital. He received his medical degree from Rutgers Robert Wood Johnson Medical School and has been in practice 24 years. He specializes in pediatric critical care medicine.
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Critical Care Medicine, 1996 - 1999
- Children's National HospitalResidency, Pediatrics, 1993 - 1996
- Rutgers Robert Wood Johnson Medical SchoolClass of 1993
Certifications & Licensure
- NJ State Medical License 2005 - 2025
- NY State Medical License 1996 - 2019
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Critical Care Medicine
Publications & Presentations
PubMed
- 130 citationsThe histone deacetylase inhibitor, CBHA, inhibits growth of human neuroblastoma xenografts in vivo, alone and synergistically with all-trans retinoic acid.Dennis C. Coffey, Martha C. Kutko, Richard D. Glick, Lisa M. Butler, Glenn Heller
Cancer Research. 2001-05-01 - 145 citationsHybrid Polar Histone Deacetylase Inhibitor Induces Apoptosis and CD95/CD95 Ligand Expression in Human NeuroblastomaRichard D. Glick, Steven L. Swendeman, Dennis C. Coffey, Richard A. Rifkind, Paul A. Marks
Cancer Research. 1999-09-01 - 49 citationsHistone deacetylase inhibitors and retinoic acids inhibit growth of human neuroblastoma in vitro.Dennis C. Coffey, Martha C. Kutko, Richard D. Glick, Steven L. Swendeman, Lisa M. Butler
Medical and Pediatric Oncology. 2000-12-01
Press Mentions
- Severe Respiratory Illness Cases Possibly Tied to Vaping Rises to 152 in 16 StatesJune 8th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: